These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7375800)

  • 1. Dietary control of hyperlipoproteinemia.
    Lacatîs D; Bălan M; Creţeanu G
    Med Interne; 1980; 18(1):49-53. PubMed ID: 7375800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dietetic treatment of hyperlipoproteinemias].
    Louis J; Antoine JM; Pointel JP; Debry G; Drouin P
    Sem Hop; 1983 Sep; 59(32):2273-8. PubMed ID: 6314517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diet treatment of hyperliproteinemias].
    Louis J; Antoine JM; Pointel JP; Debry G; Drouin P
    Pathol Biol (Paris); 1983 Apr; 31(4):277-82. PubMed ID: 6346241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of high density lipoprotein cholesterol and apoliproprotein A-I concentrations by a lipid-lowering diet.
    Vessby B; Boberg J; Gustafsson IB; Karlström B; Lithell H; Ostlund-Linqvist AM
    Atherosclerosis; 1980 Jan; 35(1):21-7. PubMed ID: 6768372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Indications for and the therapeutic action of hypolipidemic agents in patients with hyperlipoproteinemias].
    Goranov I; Naumova R; Kerekovska M; Balabanski L
    Vutr Boles; 1987; 26(1):96-101. PubMed ID: 3590738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of avocado on the level of blood lipids in patients with phenotype II and IV dyslipidemias].
    Carranza J; Alvizouri M; Alvarado MR; Chávez F; Gómez M; Herrera JE
    Arch Inst Cardiol Mex; 1995; 65(4):342-8. PubMed ID: 8561655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hyperlipoproteinemia, types II and IV, with pirifibrate: one hundred observations.
    Bonora V; Calalabuig RJ; Caviola E; Soler J; Pueyo JM; Micaló T; Cano RP
    Clin Ther; 1981; 4(3):192-200. PubMed ID: 7030489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pirifibrate in the treatment of hyperlipoproteinemias: a multicenter study.
    Domingo AJ; Gutiérrez JA; Menéndez JA; Micó L; Muñoz M; de Oya M
    Clin Ther; 1980; 3(3):219-26. PubMed ID: 7459931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pirifibrate in the treatment of hyperlipoproteinemia: types IIa, IIb, and IV.
    Lopez Rodriguez J; Martorell J
    Clin Ther; 1980; 3(4):234-41. PubMed ID: 7273061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment of hyperlipoproteinemia with etofibrate: clinical observations.
    Kaffarnik H; Schneider J; Schubotz R; Zöfel P; Hausmann L; Goebel KM
    Artery; 1980; 8(6):537-46. PubMed ID: 6114725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of lipid-lowering diets on patients with hyperlipoproteinemia.
    Gustafsson IB; Vessby B; Boberg J; Karlström B; Lithell H
    J Am Diet Assoc; 1982 May; 80(5):426-32. PubMed ID: 7076998
    [No Abstract]   [Full Text] [Related]  

  • 12. Dietary therapy for different forms of hyperlipoproteinemia.
    Grundy SM
    Circulation; 1987 Sep; 76(3):523-8. PubMed ID: 3621518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis of primary hyperlipoproteinemia during a preventive examination].
    Raslová K; Mongiellová V; Hucková M
    Cas Lek Cesk; 1993 Mar; 132(5):137-41. PubMed ID: 8472293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term effect of polyenic-fatty-acids-enriched diet on the relations of fatty acids and glycerophospholipids in 50- to 60-year-old HLP patients].
    Reuter W; Heybey U
    Z Alternsforsch; 1984; 39(2):63-6. PubMed ID: 6730529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HDL, HDL2 and HDL3 cholesterol in various types of hyperlipoproteinemia in relation to clinical signs of arteriosclerosis].
    Sznajderman M; Zawadzki Z
    Kardiol Pol; 1986; 29(3):194-203. PubMed ID: 3773408
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dietary treatment of patients with familial hyperlipoproteinemias].
    Solovév EIu; Rozhkova TA; Koshechkin VA; Pogozhaeva AV
    Kardiologiia; 1992; 32(11-12):56-8. PubMed ID: 1297883
    [No Abstract]   [Full Text] [Related]  

  • 17. The epidemiology of hyperlipoproteinemia in a Rumanian general population sample. Study of 7,085 cases.
    Mincu I; Ionescu-Tîrgoviste C; Stanescu J; Boboia D; Cheta D; Popa E; Mihalache N; Georgescu M
    Diabete Metab; 1976 Dec; 2(4):171-82. PubMed ID: 1017536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phenotype change in hyperlipoproteinemias].
    Meincke H
    Dtsch Z Verdau Stoffwechselkr; 1985; 45(5):236-9. PubMed ID: 4085393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of metabolic and clinical effects of polyunsaturated fatty acids omega-3 from "Eicovit" in patients with ischemic heart disease and familial hyperlipoproteinemia].
    Sorokovoĭ KV; Pogozheva AV; Kulakova SN; Lupinovich VL; Karagodina ZV; Levachev MM; Samsonov MA; Vorsanovich EA
    Vopr Pitan; 1998; (2):29-31. PubMed ID: 9680669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antithrombogenic activity of the vascular wall, hemostasis, and rheological characteristics of blood in patients with unstable angina pectoris and various types of hyperlipoproteinemia].
    Kirichuk VF; Voskoboĭ IV
    Ter Arkh; 2000; 72(12):47-50. PubMed ID: 11201832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.